| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.0B | $-0.1B | $0.0B | $0.1B | $0.0B | $0.1B | $0.1B | $-0.1B |
| EPS (Basic) | $0.08 | $-2.07 | $0.05 | $0.34 | $0.00 | $0.55 | $0.60 | $-0.63 |
| EPS (Diluted) | $1.72 | $1.10 | $0.23 | $-2.51 | $2.44 | $0.07 | $1.81 | $1.96 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $15.8B | $13.1B | $12.9B | $13.4B | $15.4B | $17.5B | $27.1B | $27.7B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.3B | $0.1B | $0.2B | $0.3B | $0.4B | $0.3B | $0.1B | $0.0B |
| Total Liabilities | $13.2B | $10.6B | $10.4B | $10.7B | $11.7B | $13.7B | $23.2B | $24.0B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $2.6B | $2.5B | $2.6B | $2.7B | $3.7B | $3.8B | $4.0B | $3.7B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $-0.2B | $0.2B | $0.2B | $0.3B | $0.5B | $0.3B | $0.1B | $0.3B |
| Investing Cash Flow | $-1.7B | $0.2B | $0.6B | $0.5B | $2.5B | $8.3B | $1.2B | $-6.0B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $2.1B | $-0.5B | $-0.8B | $-1.0B | $-3.0B | $-8.4B | $-1.2B | $5.7B |